Product Information
ROPINIROLE HCL ER 4 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.5707 per EA under NDC 62332010830. Its NADAC has been published 276 times since Mar 17, 2021.
Strength
4 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332010830
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202786On Market Since
6/20/2020
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL ER 4 MG TABLET has been published 276 times since Mar 17, 2021, and over the history we have for it it has declined 53.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5707 per EA |
|---|---|
| All-time high | $1.3871 (Sep 15, 2021) |
| All-time low | $0.4819 (Nov 20, 2024) |
| 52-week high | $0.8533 |
| 52-week low | $0.5707 |
| Median price | $0.8068 |
| Average price | $0.8166 |
| Largest weekly change | +72.2% (Oct 19, 2022) |
| Weeks tracked | 276 |
| Tracking since | Mar 17, 2021 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 86% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL ER 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL ER 4 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.5707 per EA (NDC 62332010830), effective Jun 24, 2026.
How has the price of ROPINIROLE HCL ER 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL ER 4 MG TABLET has declined 53.1%. It has been tracked across 276 weekly CMS publications since Mar 17, 2021.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL ER 4 MG TABLET?
Since Mar 17, 2021, the NADAC for ROPINIROLE HCL ER 4 MG TABLET has ranged from a low of $0.4819 (Nov 20, 2024) to a high of $1.3871 (Sep 15, 2021), with a median of $0.8068 per EA.
Are there cheaper alternatives to ROPINIROLE HCL ER 4 MG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ROPINIROLE HCL 4 MG TABLET, is $0.0804 per EA — about 86% below ROPINIROLE HCL ER 4 MG TABLET.
Who manufactures ROPINIROLE HCL ER 4 MG TABLET?
ROPINIROLE HCL ER 4 MG TABLET (NDC 62332010830) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification